Effect of Xuebijing injection on T helper 17 and CD4 +CD25 + regulatory T cells in patients with sepsis

Chinese Critical Care Medicine

Volumn 23, Issue 7, 2011, Pages 430-434

  Shao, Min ^a   Liu, Bao ^b   Wang, Jin Quan ^b   Tao, Xiao Geng ^b   Zhou, Shu Sheng ^b   Jin, Kui ^b   Zhang, Cui Ping ^b  

^a ANHUI PROVINCIAL HOSPITAL   (China)

^b NONE

Author keywords

CD4 +CD25 + regulatory T cell; Helper T cell 17; Immune balance; Sepsis; Xuebijing injection

Indexed keywords

CHINESE DRUG; LACTIC ACID; UNCLASSIFIED DRUG; XUEBIJING;

ARTICLE; CD4+ CD25+ T LYMPHOCYTE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE SEVERITY; FLOW CYTOMETRY; HUMAN; INTENSIVE CARE UNIT; LACTATE BLOOD LEVEL; LENGTH OF STAY; MORTALITY; RANDOMIZED CONTROLLED TRIAL; REGULATORY T LYMPHOCYTE; SEPSIS; SEPTIC SHOCK; TH17 CELL;

AGED; DRUGS, CHINESE HERBAL; FEMALE; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; SEPSIS; T-LYMPHOCYTES, REGULATORY; TH17 CELLS;

EID: 80051947546     PISSN: 10030603     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.1003-0603.2011.07.014     Document Type: Article

References (22)

1. Lee YK, Turner H, Maynard CL, et al. Late developmental plasticity in the T helper 17 lineage. Immunity, 2009,30:92-107.
2. Schmidt-Weber CB, Akdis M, Akdis CA, et al. TH17 cells in the big picture of immunology. J Allergy Clin Immunol, 2007, 120:247-254. (Pubitemid 47102403)
3. +CD127-regulatory T cells and inflammatory response and outcome during shock states. Crit Care, 2010,14:R19.
4. Ohkura N, Sakaguchi S. Regulatory T cells: roles of T cell receptor for their development and function. Semin Immunopathl, 2010,32:95-106.
5. Afzali B, Lombardi G, Lechler RI, et al. The role of T helper 17 (Th17) and regulatory T cells (Treg) in human organ transplanation and autoimmune disease. Clin Exp Immunol, 2007,148:32-46. (Pubitemid 46365005)
6. Bone RC, Balk RA, Cerra FB, et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Chest, 1992,101:1644-1655.
7. Levy MM, Fink MP, Marshall JC, et al. 2001 SCCM/ESICM/ACCP/ATS/SIS international sepsis definitions conference. Crit Care Med, 2003,31:1250-1256.
8. Dellinger RP, Carlet JM, Masur H, et al. Surviving sepsis campaign guidelines for management of severe sepsis and septic shock. Crit Care Med, 2004,32:858-873. (Pubitemid 38344143)
9. high T-regulatory cells in recipients and their corresponding donors to acute GVHD. Transpl Int, 2007,20:440-446.
10. Bettelli E, Oukka M, Kuchroo VK. TH17 cells in the circle of immunity and autoimmunity. Nat Immunol, 2007,8:345-350. (Pubitemid 46745409)
11. Conti HR, Shen F, Nayyar H, et al. Th17 cells and IL-17 receptor signaling are essential for mucosal host defense against oral candidiasis. J Exp Med, 2009,206:299-311.
12. Smith E, Stark MA, Zarbock A, et al. IL-17A inhibits the expansion of IL-17A-producing T cells in mice through "short-loop" inhibition via IL-17 receptor. J Immunol, 2008, 181:1357-1364.
13. Bettelli E, Carrier Y, Gao W, et al. Reciprocal developmental pathways for the generation of pathogenic effector Th17 and regulatory T cells. Nature, 2006,441:235-238.
14. Weaver CT, Hatton RD, Mangan PR, et al. IL-17 family cytokines and the expanding diversity of effector T cell lineages. Annu Rev Immunol, 2007,25:821-852.